Amanda K. Mika

Potent and selective inhibitors of Akt kinases slow the progress of tumors <i>in vivo</i>

Yan Luo, Alexander R. Shoemaker, Xuesong Liu et al. · Molecular Cancer Therapeutics · 2005 · 244 citations · Full text

Medicine, Oncology, Pharmacology +15

Hepatic Glucocorticoid Receptor Antagonism Is Sufficient to Reduce Elevated Hepatic Glucose Output and Improve Glucose Control in Animal Models of Type 2 Diabetes

Peer B. Jacobson, Thomas W von Geldern, Lars Öhman et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 77 citations · Full text

Medicine, Endocrinology, Pharmacology +16

Discovery and Structure−Activity Relationship of Oxalylarylaminobenzoic Acids as Inhibitors of Protein Tyrosine Phosphatase 1B

Gang Liu, Bruce G. Szczepankiewicz, Zhonghua Pei et al. · Journal of Medicinal Chemistry · 2003 · 63 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse

Vikkie A. Mustad, Stephen J. DeMichele, Y. S. Huang et al. · Metabolism · 2006 · 62 citations

Life Sciences, Endocrinology, Nutritional Sciences +17

Discovery, Structure−Activity Relationship, and Pharmacological Evaluation of (5-Substituted-pyrrolidinyl-2-carbonyl)-2-cyanopyrrolidines as Potent Dipeptidyl Peptidase IV Inhibitors

Zhonghua Pei, Xiaofeng Li, Kenton L. Longenecker et al. · Journal of Medicinal Chemistry · 2006 · 61 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16